1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Birch Pollen Allergy Global Clinical Trials Review, H2, 2014

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 77 pages

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Birch Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Birch Pollen Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Birch Pollen Allergy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Birch Pollen Allergy to Immunology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Birch Pollen Allergy to Immunology Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Birch Pollen Allergy 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Birch Pollen Allergy Therapeutics Clinical Trials 24
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Stallergenes S.A. 27
Clinical Trial Overview of Stallergenes S.A. 27
Merck KGaA 28
Clinical Trial Overview of Merck KGaA 28
Anergis SA 29
Clinical Trial Overview of Anergis SA 29
Allergy Therapeutics plc 30
Clinical Trial Overview of Allergy Therapeutics plc 30
HAL Allergy BV 31
Clinical Trial Overview of HAL Allergy BV 31
ALK-Abello A/S 32
Clinical Trial Overview of ALK-Abello A/S 32
Laboratorios LETI S.L. 33
Clinical Trial Overview of Laboratorios LETI S.L. 33
Marinomed Biotechnologie GmbH 34
Clinical Trial Overview of Marinomed Biotechnologie GmbH 34
E. I. du Pont de Nemours and Company 35
Clinical Trial Overview of E. I. du Pont de Nemours and Company 35
Artu Biologicals 36
Clinical Trial Overview of Artu Biologicals 36
Clinical Trial Overview of Top Institutes / Government 37
Medical University of Vienna 37
Clinical Trial Overview of Medical University of Vienna 37
UMC Utrecht Holding BV 38
Clinical Trial Overview of UMC Utrecht Holding BV 38
Royal Sussex County Hospital 39
Clinical Trial Overview of Royal Sussex County Hospital 39
Oulu University Hospital 40
Clinical Trial Overview of Oulu University Hospital 40
Sahlgrenska University Hospital 41
Clinical Trial Overview of Sahlgrenska University Hospital 41
Royal Brompton and Harefield NHS Foundation Trust 42
Clinical Trial Overview of Royal Brompton and Harefield NHS Foundation Trust 42
University of Zurich 43
Clinical Trial Overview of University of Zurich 43
Rijnstate Hospital 44
Clinical Trial Overview of Rijnstate Hospital 44
Five Key Clinical Profiles 45
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

List of Tables
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Birch Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Birch Pollen Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Birch Pollen Allergy Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Birch Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Birch Pollen Allergy to Immunology Clinical Trials, E7 Countries (%), 2014* 15
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Birch Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Birch Pollen Allergy Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Birch Pollen Allergy Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Birch Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stallergenes S.A., 2014* 27
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014* 28
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anergis SA, 2014* 29
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014* 30
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by HAL Allergy BV, 2014* 31
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2014* 32
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014* 33
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Marinomed Biotechnologie GmbH, 2014* 34
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by E. I. du Pont de Nemours and Company, 2014* 35
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Artu Biologicals, 2014* 36
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 37
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 38
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Sussex County Hospital, 2014* 39
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Oulu University Hospital, 2014* 40
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2014* 41
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Brompton and Harefield NHS Foundation Trust, 2014* 42
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 43
Birch Pollen Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rijnstate Hospital, 2014* 44

List of Figures
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Birch Pollen Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Birch Pollen Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Birch Pollen Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 12
Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Birch Pollen Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Birch Pollen Allergy to Immunology Clinical Trials, E7 Countries (%), 2014* 15
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Birch Pollen Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Birch Pollen Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Birch Pollen Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Birch Pollen Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Birch Pollen Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.